Abstract
The article presents modern approaches to antithrombotic therapy in patients with acute coronary syndrome (ACS) according to the European Society of Cardiology Guidelines from 2023 [1]. The algorithm for prescribing antiplatelet drugs and the features of the use of loading doses, the principles of treatment with anticoagulants in the acute phase of ACS are analyzed. Alternative antiplatelet strategies are reviewed, considering bleeding risk. The importance of a personalized approach to the management of ACS patients is emphasized.
References
Бенца ТМ. Дисплазія сполучної тканини: особливості клінічних проявів, діагностики та лікування / ТМ Бенца. Ліки України. 2021;7:28-31. 2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023;00:1-107.
Timmis A, Kazakiewicz D, Townsend N, Huculeci R, Aboyans V, Vardas P. Global epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2023;20(11):778-788. doi: 10.1038/s41569-023-00884-0.
Nohria R, Antono B. Acute Coronary Syndrome. Prim Care. 2024;51(1):53-64. doi: 10.1016/j.pop.2023.07.003.